|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Uric Acid
Test CodeURIC
Alias/See Also
URCA, URIC
Preferred Specimen
1.0 mL plasma (0.5 mL minimum)
Transport Container
PST (light green top). Red top and SST also acceptable
Specimen Stability
Room temperature: 1 day, Refrigerated: 3-5 days, Frozen: 6 months
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Grossly hemolyzed specimens are unacceptable.
Limitations
Xanthine has been reported to decrease the URCA result by 40%. Formaldehyde (formalin) has been reported to give negative interference.
Reference Range
Age | Female | Male |
Adult (>19 years): | 2.6-7.2 mg/dL | 2.6-7.2 mg/dL |
Pediatric: | ||
0 – 31 days | 1.3-6.2 | 1.2-4.9 |
1 – 3 months | 1.3-5.8 | 1.3-5.3 |
4 - 6 months | 1.3-6.2 | 1.4-6.4 |
7 – 12 months | 1.4-6.2 | 1.4-6.7 |
1 – 3 years | 1.7-5.0 | 1.7-5.0 |
4 – 6 years | 2.2-4.7 | 2.2-4.7 |
7 – 9 years | 1.9-5.0 | 1.9-5.0 |
10 – 11 years | 3.0-4.7 | 2.3-5.4 |
12 – 13 years | 3.0-5.8 | 2.7-6.8 |
14 – 15 years | 3.0-5.8 | 2.4-7.9 |
16 – 19 years | 3.0-5.9 | 4.0-8.7 |
Clinical Significance
Numerous metabolic disorders result in abnormal uric acid levels, as well as wasting diseases, thyroid disorders, psoriasis, decreased renal function, polycystic kidney, gout, arteriosclerosis, hypertension, and treatment with chemotherapeutic agents. High levels of purines in the diet, or conditions leading to increased destruction of nucleoproteins (e.g. leukemia, hemolytic anemia, sickle cell anemia, and others) may result in increased uric acid levels. Low levels have been associated with a number of disorders, including xanthinuria and treatment with uricosuric drugs, cortisone, coumarins, or high doses of salicylates.